These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30238691)

  • 1. Fluorinated Acid-Labile Branched Hydroxyl-Rich Nanosystems for Flexible and Robust Delivery of Plasmids.
    Qi Y; Song H; Xiao H; Cheng G; Yu B; Xu FJ
    Small; 2018 Oct; 14(42):e1803061. PubMed ID: 30238691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenylboronic acid-functionalized polyaminoglycoside as an effective CRISPR/Cas9 delivery system.
    Shao M; Qi Y; Sui D; Xu FJ
    Biomater Sci; 2021 Oct; 9(21):7104-7114. PubMed ID: 34704559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional Vector for Delivery of Genome Editing Plasmid Targeting β-Catenin to Remodulate Cancer Cell Properties.
    He XY; Liu BY; Peng Y; Zhuo RX; Cheng SX
    ACS Appl Mater Interfaces; 2019 Jan; 11(1):226-237. PubMed ID: 30540162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cationic Polymer-Mediated CRISPR/Cas9 Plasmid Delivery for Genome Editing.
    Zhang Z; Wan T; Chen Y; Chen Y; Sun H; Cao T; Songyang Z; Tang G; Wu C; Ping Y; Xu FJ; Huang J
    Macromol Rapid Commun; 2019 Mar; 40(5):e1800068. PubMed ID: 29708298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene editing in clinical isolates of Candida parapsilosis using CRISPR/Cas9.
    Lombardi L; Turner SA; Zhao F; Butler G
    Sci Rep; 2017 Aug; 7(1):8051. PubMed ID: 28808289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Lactose-Derived CRISPR/Cas9 Delivery System for Efficient Genome Editing In Vivo to Treat Orthotopic Hepatocellular Carcinoma.
    Qi Y; Liu Y; Yu B; Hu Y; Zhang N; Zheng Y; Yang M; Xu FJ
    Adv Sci (Weinh); 2020 Sep; 7(17):2001424. PubMed ID: 32995132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges.
    Mout R; Ray M; Lee YW; Scaletti F; Rotello VM
    Bioconjug Chem; 2017 Apr; 28(4):880-884. PubMed ID: 28263568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-Cas9-mediated genome editing in apple and grapevine.
    Osakabe Y; Liang Z; Ren C; Nishitani C; Osakabe K; Wada M; Komori S; Malnoy M; Velasco R; Poli M; Jung MH; Koo OJ; Viola R; Nagamangala Kanchiswamy C
    Nat Protoc; 2018 Dec; 13(12):2844-2863. PubMed ID: 30390050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Research progress of CRISPR-Cas9 system for gene therapy].
    Zhan C; Xia X
    Sheng Wu Gong Cheng Xue Bao; 2016 Jul; 32(7):861-869. PubMed ID: 29019208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9 Immune System as a Tool for Genome Engineering.
    Hryhorowicz M; Lipiński D; Zeyland J; Słomski R
    Arch Immunol Ther Exp (Warsz); 2017 Jun; 65(3):233-240. PubMed ID: 27699445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice.
    Ohmori T; Nagao Y; Mizukami H; Sakata A; Muramatsu SI; Ozawa K; Tominaga SI; Hanazono Y; Nishimura S; Nureki O; Sakata Y
    Sci Rep; 2017 Jun; 7(1):4159. PubMed ID: 28646206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of CRISPR/Cas9 gene-editing tools for developing models in drug discovery.
    Ahmad G; Amiji M
    Drug Discov Today; 2018 Mar; 23(3):519-533. PubMed ID: 29326075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fabrication and characterization of PLGA nanoparticles encapsulating large CRISPR-Cas9 plasmid.
    Jo A; Ringel-Scaia VM; McDaniel DK; Thomas CA; Zhang R; Riffle JS; Allen IC; Davis RM
    J Nanobiotechnology; 2020 Jan; 18(1):16. PubMed ID: 31959180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced mutation and epigenetics modification in plants for crop improvement by targeting CRISPR/Cas9 technology.
    Khan MHU; Khan SU; Muhammad A; Hu L; Yang Y; Fan C
    J Cell Physiol; 2018 Jun; 233(6):4578-4594. PubMed ID: 29194606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and application of CRISPR/Cas9 technologies in genomic editing.
    Zhang C; Quan R; Wang J
    Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymeric micellar nanoparticles for effective CRISPR/Cas9 genome editing in cancer.
    Li Y; Li C; Yan J; Liao Y; Qin C; Wang L; Huang Y; Yang C; Wang J; Ding X; Yang YY; Yuan P
    Biomaterials; 2024 Sep; 309():122573. PubMed ID: 38677222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cas9, Cpf1 and C2c1/2/3-What's next?
    Nakade S; Yamamoto T; Sakuma T
    Bioengineered; 2017 May; 8(3):265-273. PubMed ID: 28140746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AAV-Mediated CRISPR/Cas Gene Editing of Retinal Cells In Vivo.
    Hung SS; Chrysostomou V; Li F; Lim JK; Wang JH; Powell JE; Tu L; Daniszewski M; Lo C; Wong RC; Crowston JG; Pébay A; King AE; Bui BV; Liu GS; Hewitt AW
    Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3470-6. PubMed ID: 27367513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein.
    Tang L; Zeng Y; Du H; Gong M; Peng J; Zhang B; Lei M; Zhao F; Wang W; Li X; Liu J
    Mol Genet Genomics; 2017 Jun; 292(3):525-533. PubMed ID: 28251317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.